Use of arginine-glycine-aspartic acid adhesion peptides coupled with a new collagen scaffold to engineer a myocardium-like tissue graft

Nature Clinical Practice Cardiovascular Medicine

Volumn 6, Issue 3, 2009, Pages 240-249

  Schussler, Olivier ^a,b   Coirault, Catherine ^c,d   Louis Tisserand, Mariana ^a   Al Chare, Walid ^a   Oliviero, Patricia ^c   Menard, Claudine ^e   Michelot, Robert J ^a   Bochet, Pascal ^f   Salomon, Daniel R ^g   Chachques, Juan C ^a   Carpentier, Alain ^a   Lecarpentier, Yves ^d,h  

^a HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^b UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

^c INSERM   (France)

^d BICÊTRE HOSPITAL   (France)

^e CNRS   (France)

^f Universite Paris Sud   (France)

^g MEM 241   (United States)

^h CENTRE HOSPITALIER DE MEAUX   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARGINYLGLYCYLASPARTIC ACID; COLLAGEN;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL VIABILITY; CONTROLLED STUDY; HEART CELL CULTURE; HEART GRAFT; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILITY; MUSCLE FIBER CONTRACTION; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAT; TISSUE ENGINEERING;

EID: 61449131494     PISSN: 17434297     EISSN: 17434300     Source Type: Journal    
DOI: 10.1038/ncpcardio1451     Document Type: Article

References (45)

1. Zimmermann WH and Eschenhagen T (2003) Cardiac tissue engineering for replacement therapy. Heart Fail Rev 8:259-269
2. Zimmermann WH et al. (2006) Engineered heart tissue grafts improve systolic and diastolic function in infarcted rat hearts. Nat Med 12: 452-458 3
3. Akhyari P et al. (2002) Mechanical stretch regimen enhances the formation of bioengineered autologous cardiac muscle grafts. Circulation 106:1137-1142
4. Fink C et al. (2000) Chronic stretch of engineered heart tissue induces hypertrophy and functional improvement. Faseb J 14: 669-6795
5. Radisic M et al. (2004) Functional assembly of engineered myocardium by electrical stimulation of cardiac myocytes cultured on scaffolds. Proc Natl Acad Sci U S A 101: 18129-18134
6. Radisic M et al. (2004) Medium perfusion enables engineering of compact and contractile cardiac tissue. Am J Physiol Heart Circ Physiol 286: H507-H1516
7. Papadaki M et al. (2001) Tissue, engineering of functional cardiac muscle: Molecular, structural, and electrophysiological studies. Am J Physiol Heart Circ Physiol 280: H168-H178
8. Giraud MN et al. (2007) Current state of the art in myocardial tissue engineering. Tissue Eng 13: 1825-1836
9. Caplice NM (2006) The future of cell therapy for acute myocardial infarction. Nat Clin Pract Cardiovasc Med 3 (Suppl 1): S129-S132
10. Yacoub M et al. (2006) The future of regenerative therapy in patients with chronic heart failure. Nat Clin Pract Cardiovasc Mad 3 (Suppl 1): S133-S135
11. Torella D et al. (2006) Resident human cardiac stem cells: Role in cardiac cellular homeostasis and potential for myocardial regeneration. Nat Clin Pract Cardiovasc Med 3 (Suppl 11): S8-S13
12. Adler ED and Maddox TM (2007) Cell therapy for cardiac disease: Where do we go from here? Nat Clin Pract Cardiovasc Med 4: 2-3
13. Aldhous P (2007) Stem-cell research: After the gold rush. Nature 434: 694-696
14. Nadal-Ginard B and Fuster V (2007) Myocardial cell therapy at the crossroads. Nat Clin Pract Cardiovasc Med 4: 1
15. Akhyari P et al. (2008) Myocardial tissue engineering: The extracellular matrix. Eur J Cardiothorac Surg 34: 229-241
16. Masuda S et al. (2008) Cell sheet engineering for heart tissue repair. Adv Drug Deliv Rev 60: 277-285
17. Radisic M et al. (2008) Cardiac tissue engineering using perfusion bioreactor systems. Nat Protoc 3: 719-738
18. Christman KL and Lee RJ (2006) Biomaterials for the treatment of myocardial infarction. J Am Coll Cardiol 48: 907-913
19. Fuster V and Sanz J (2007) Gene therapy and stem cell therapy for cardiovascular diseases today: A model for translational research. Nat Clin Pract Cardiovasc Med 4 (Suppl 1): S1-S8
20. Pucéat M and Ballis A (2007) Embryonic stem cells: From bench to bedside. Clin Pharmacol Ther 82: 337-339
21. Samarel AM (2005) Costameres, focal adhesions, and cardiomyocyte mechanotransduction. Am J Physiol Heart Circ Physiol 289; H2291-H2301
22. Griffith LG and Swartz MA (2006) Capturing complex 3D tissue physiology in vitro. Nat Rev Mol Cell Biol 7: 211-224
23. Parker KK et al. (2008) Myofibrillar architecture in engineered cardiac myocytes. Circ Res 103: 340-342
24. Ross RS and Borg TK (2001) Integring and the myocardium. Circ Res 88: 1112-1119
25. Srivastava D and Yu S (2006) Stretching to meet needs: Integrin-linked kinase and the cardiac pump. Genes Dev 20: 2327-2331
26. Kuhn B et al. (2007) Periostin induces proliferation of differentiated cardiomyocytes and promotes cardiac repair. Nat Med 13: 962-969
27. Brancaccio M et al. (2006) Integrin signalling: The tug-of-war in heart hypertrophy. Cardiovasc Res 70: 422-433
28. Darribère T et al. (2000) Integrins: Regulators of embryogenesis. Biol Cell 92: 5-25
29. Shimazaki M et al. (2008) Periostin is essential for cardiac healing after acute myocardial infarction. J Exp Med 205: 295-303
30. Knowlton KU et al. (1991) Co-regulation of the atrial natriuretic factor and cardiac myosin light chain-2 genes during alpha-adrenergic stimulation of neonatal rat ventricular cells. Identification of cis sequences within an embryonic and a constitutive contractile protein gene which mediate inducible expression. J Biol Chem 266: 7759-7768
31. Dar A et al. (2002) Optimization of cardiac cell seeding and distribution in 3D porous alginate scaffolds. Biotechnol Bioeng 80: 305-312
32. Zimmermann WH et al. (2002) Cardiac grafting of engineered heart tissue in syngenic rats. Circulation 106: I151-I157
33. Mandarim-De-Lacerda CA and Meirelles Pereira LM (2000) Numerical density of cardiomyocytes in chronic nitric oxide synthesis inhibition. Pathobiology 68: 36-42
34. Borenfreund E and Puerner JA (1985) Toxicity determined in vitro by morphological alterations and neutral red absorption. Toxicol Lett 24: 119-124
35. -/- mice. Am J Physiol Heart Circ Physiol 293: H93-H102
36. Lecarpentier Y and Coirault C (1998) Mechanics, energetics, and crossbridge kinetics of rabbit diaphragm during congestive heart failure. Faseb J 12: 981-989
37. Vogel V and Sheetz M (2006) Local force and geometry sensing regulate cell functions. Nat Rev Mol Cell Biol 7: 265-275
38. Wood MA et al. (2008) The β integrins and cytoskeletal nanoimprinting. Exp Cell Res 314: 927-935
39. Myles JL et al. (2000) Modification of the adhesive properties of collagen by covalent grafting with RGD peptides. J Biomater Sci Polym Ed 11: 69-86
40. Beer JH et al. (1992) Immobilized Arg-Gly-Asp (RGD) peptides of varying lengths as structural probes of the platelet glycoprotein IIb/ IIIa receptor. Blood 79: 117-128
41. Craig WS et al. (1995) Concept and progress in the development of RGD-containing peptide pharmaceuticals. Biopolymers 37: 157-175
42. Kofidis T et al. (2003) Clinically established hemostatic scaffold (tissue fleece) as biomatrix in tissue- and organ-engineering research. Tissue Eng 9: 517-523
43. Lecarpentier Y (1985) Real-time kinetics of sarcomere relaxation by laser diffraction. Circ Res 56: 331-339
44. Valencik ML et al. (2006) Integrin activation in the heart: A link between electrical and contractile dysfunction? Circ Res 99: 1403-1410
45. Chachques JC et al. (2006) Myocardial Assistance by Grafting a New Bioartificial Upgraded Myocardium (MAGNUM Trial): Clinical feasability study. Circulation 114 (Suppl II): II-566